Florbetaben PET shows strength in assessing for Alzheimer’s

September 11, 2015

PET scans augmented by injections of the beta-amyloid targeting tracer florbetaben F18 are effective at helping confirm or rule out Alzheimer’s disease in patients under evaluation for cognitive impairment.

The study behind the conclusion is running in the current edition of  Alzheimer’s & Dementia.

Read the full story.